Assessing Natural Health Product-Drug Interactions and Coding Feasibility: Analysis of a New Zealand General Population Dataset from an Online Market Research Panel - Report - MDSpire
Advertisement
Assessing Natural Health Product-Drug Interactions and Coding Feasibility: Analysis of a New Zealand General Population Dataset from an Online Market Research Panel
Evaluating Interactions Between Natural Health Products and Medications
Overview
This study reveals that 71.1% of natural health product (NHP) users in New Zealand concurrently use conventional medicines, highlighting potential safety concerns. The study also identifies challenges in coding NHPs, emphasizing the need for a standardized coding dictionary to enhance monitoring and analysis.
Background
Natural health products (NHPs) are widely used and often self-prescribed, raising safety concerns regarding their interactions with conventional medicines. The prevalence of concurrent use of NHPs and conventional drugs necessitates careful monitoring to prevent adverse drug reactions (ADRs). Despite their perceived safety, serious ADRs linked to NHPs have been documented, underscoring the importance of understanding these interactions.
Data Highlights
No numerical data available.
Key Findings
71.1% of NHP users in New Zealand were concurrently using conventional medicines.
Natural health product-drug combinations were identified that may lead to adverse reactions.
Approximately one-third of NHPs could not be coded using WHODrug, indicating a need for a standardized coding dictionary.
Serious ADRs associated with NHPs, such as hepatotoxicity and increased bleeding risk, have been reported.
Effective monitoring of NHP use requires consistent data collection and coding.
Clinical Implications
Healthcare professionals should be aware of the high prevalence of concurrent NHP and conventional medicine use among patients. It is crucial to inquire about NHP use during consultations to mitigate potential adverse drug reactions and ensure patient safety.
Conclusion
The findings underscore the necessity for improved monitoring and coding of NHPs to safeguard public health. Enhanced awareness and communication about NHP use among healthcare providers can help prevent adverse interactions.
